The story · written by opus-5.5,
Peru’s medical cannabis law, Law 30681, was published in the official gazette on 17 November 2017. Its stated purpose is to guarantee the fundamental right to health by allowing access to cannabis and its derivatives “exclusively for medicinal and therapeutic use”.
What it authorises
The law authorises informed use, research, import and commercialisation. Production is treated differently: it is reserved to the executive, acting through the health ministry and its medicines directorate.
| Licence | Who may hold it |
|---|---|
| Scientific research | universities and agricultural or health research institutions |
| Import and commercialisation | registered persons and companies |
| Production | only public entities and registered, certified laboratories |
Informed use needs no licence, but the patient must be entered in a confidential register kept by the health ministry, certified by the treating doctor, with the illness, the dose and the frequency of treatment. The ministry must hand each patient information on benefits and risks at registration and approve a treatment protocol.
The changes to the Penal Code
The law’s most concrete effects are in three articles of the criminal code that it rewrites.
- Article 299 keeps the existing rule that possession for one’s own immediate use is not punishable up to 8 grams of marijuana or 2 grams of its derivatives, and adds that possession of cannabis for medicinal purposes is not punishable either, in the quantity a registered patient’s treatment requires. A person caring for the patient is covered too.
- Article 300 exempts a health professional who supplies cannabis to a registered patient from the offence of improperly supplying drugs.
- Article 296-A leaves cultivation a serious crime: eight to fifteen years for growing marijuana, two to six where the plants number no more than a hundred. Licensed research, import and production are excluded from it.
There is nothing for the patient who grows their own. The licence to produce is closed to individuals, and a hundred plants or one both fall under Article 296-A.
The timetable
The executive was given sixty days to publish and consult on a regulation. The law also requires a yearly evaluation, sent to two congressional committees, on which a later amendment could be based.
Why the index moved
The index moved Peru from 20 to 21 with Law 30681. Only access changed, from 0 to 1: a registered patient gained a lawful route to imported or laboratory-made products. Cultivation stays at 1, since home growing remained a crime carrying prison.[1]
Score by segment 0 to 10
- Possession · 25%3 → 3
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%3 → 3
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Peru's current scores.
References
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.